Literature DB >> 9020851

Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility.

J S Tapanainen1, K Aittomäki, J Min, T Vaskivuo, I T Huhtaniemi.   

Abstract

Gonadal function is controlled by the two pituitary gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH). While LH mainly regulates gonadal steroidogenesis, FSH is considered essential for folliculogenesis in the female and spermatogenesis in the male. We recently discovered that an inactivating point mutation in the FSH receptor (R) gene causes a recessively inherited form of hypergonadotropic ovarian failure in homozygous females. This 566C-->T mutation, predicting an alanine to valine substitution, is located in exon 7 of the FSHR gene, in the region encoding the extracellular domain of the receptor molecule. Functional testing showed a clear-cut reduction in ligand binding and signal transduction by the mutated receptor. Hence, lack of FSH function is incompatible with ovarian follicular maturation and female fertility. In the male, FSH is generally considered essential for the pubertal initiation of spermatogenesis and maintenance of quantitatively normal sperm production in adults. We report here the first characterization of males homozygous for an inactivating FSHR mutation. They have variable degrees of spermatogenic failure, but, surprisingly, do not show azoospermia or absolute infertility. These results question the essential role of FSH for the initiation of spermatogenesis, and demonstrate that FSH is more important for female than for male fertility.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9020851     DOI: 10.1038/ng0297-205

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  84 in total

Review 1.  Molecular approaches to contraceptive development.

Authors:  U Natraj
Journal:  J Biosci       Date:  2001-11       Impact factor: 1.826

Review 2.  The ovarian gonadotropin receptors in health and disease.

Authors:  Paul A Fowler; Ilpo T Huhtaniemi
Journal:  Rev Endocr Metab Disord       Date:  2002-01       Impact factor: 6.514

Review 3.  New disorders in carbohydrate metabolism: congenital disorders of glycosylation and their impact on the endocrine system.

Authors:  Bradley S Miller; Hudson H Freeze
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

4.  Association of a missense change in the D2 dopamine receptor with myoclonus dystonia.

Authors:  C Klein; M F Brin; P Kramer; M Sena-Esteves; D de Leon; D Doheny; S Bressman; S Fahn; X O Breakefield; L J Ozelius
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

Review 5.  Pharmacoperones: a new therapeutic approach for diseases caused by misfolded G protein-coupled receptors.

Authors:  Alfredo Ulloa-Aguirre; P Michael Conn
Journal:  Recent Pat Endocr Metab Immune Drug Discov       Date:  2011-01

Review 6.  The key role of vitamin A in spermatogenesis.

Authors:  Cathryn A Hogarth; Michael D Griswold
Journal:  J Clin Invest       Date:  2010-04-01       Impact factor: 14.808

7.  Germinal Cell Aplasia in Kif18a Mutant Male Mice Due to Impaired Chromosome Congression and Dysregulated BubR1 and CENP-E.

Authors:  Xue-Song Liu; Xu-Dong Zhao; Xiaoxing Wang; Yi-Xin Yao; Liang-Liang Zhang; Run-Zhe Shu; Wei-Hua Ren; Ying Huang; Lei Huang; Ming-Min Gu; Ying Kuang; Long Wang; Shun-Yuan Lu; Jun Chi; Jing-Sheng Fen; Yi-Fei Wang; Jian Fei; Wei Dai; Zhu-Gang Wang
Journal:  Genes Cancer       Date:  2010-01

Review 8.  Endocrine control of spermatogenesis: Role of FSH and LH/ testosterone.

Authors:  Suresh Ramaswamy; Gerhard F Weinbauer
Journal:  Spermatogenesis       Date:  2015-01-26

Review 9.  Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism.

Authors:  Claire Bouvattier; Luigi Maione; Jérôme Bouligand; Catherine Dodé; Anne Guiochon-Mantel; Jacques Young
Journal:  Nat Rev Endocrinol       Date:  2011-10-18       Impact factor: 43.330

Review 10.  Follicle-stimulating hormone treatment in normogonadotropic infertile men.

Authors:  Daniela Valenti; Sandro La Vignera; Rosita A Condorelli; Rocco Rago; Nunziata Barone; Enzo Vicari; Aldo E Calogero
Journal:  Nat Rev Urol       Date:  2012-12-11       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.